ClinicalTrials.Veeva

Menu

Efficacy of Xenograft Alone or Mixed With Arginyl-Glycyl-Aspartic Acid (RGD) in Horizontal Ridge Augmentation With Split-crest Technique for Implant Placement

A

Al-Azhar University

Status

Enrolling

Conditions

Implant Dentistry

Treatments

Procedure: Split crest technique
Drug: Xenograft
Drug: RGD

Study type

Interventional

Funder types

Other

Identifiers

NCT06585852
RGD in Ridge splitting

Details and patient eligibility

About

The aim of the present study is to evaluate the efficacy of xenograft alone or xenograft mixed with Arginylglycylaspartic acid (RGD) , in horizontal ridge augmentation with split-crest technique, for implant placement.

Full description

A comparative study for ridge augmentation procedure, With two groups. First group underwent a surgical ridge splitting procedure with ultrasonic bone surgery and grafting with Xenograft alone and implant placement. Second group underwent a surgical ridge splitting procedure with ultrasonic bone surgery Xenograft mix ed with Arginylglycylaspartic acid (RGD) and implant placement.

Both groups were followed up for 1 and 3 months after loading.

Enrollment

18 estimated patients

Sex

All

Ages

18 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Adults (age 18-30) exhibiting initial insufficiently bone width.
  2. Patients with good oral hygiene.
  3. Patients must be free from systemic diseases that may influence the outcome of the therapy.
  4. Patients with bony horizontal defects alone, Class III & IV.

Exclusion criteria

  1. Heavy smokers.
  2. Patient treated by immunosuppressive chemotherapy or radio therapy,
  3. Allergy to any material or medication used in the study.
  4. Pregnant females.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

18 participants in 2 patient groups

Control Group
Active Comparator group
Description:
Xenograft alone with split-crest technique by ultrasonic bone surgery and implant placement.
Treatment:
Drug: Xenograft
Procedure: Split crest technique
Study Group
Experimental group
Description:
Xenograft mixed with RGD with split-crest technique by ultrasonic bone surgery and implant placement.
Treatment:
Drug: RGD
Drug: Xenograft
Procedure: Split crest technique

Trial contacts and locations

1

Loading...

Central trial contact

Ibrahim Sabri; Mahmoud Taha, PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems